Tokai Pharmaceuticals tokaipharmaceuticals.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Tokai Pharmaceuticals (NASDAQ:TKAI) is a biopharmaceutical company focused on developing and commercializing therapies for prostate cancer and other hormonally driven diseases. The company's lead drug candidate, galeterone (TOK- 001), is an investigational new drug that can decrease overall androgen receptor levels in prostate tumors and in which three distinct mechanisms of action are combined to disrupt androgen receptor signaling in one oncotherapeutic.

Tokai Pharmaceuticals (NASDAQ:TKAI) is a biopharmaceutical company focused on developing and commercializing therapies for prostate cancer and other hormonally driven diseases. The company's lead drug candidate, galeterone (TOK- 001), is an investiga...Show all

Company (IPO / Went public)

Phone: 617-225-4305

Fax:

255 State Street
6th Floor
Boston, 02109
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Tokai Pharmaceuticals $180.6M Sep 17, 2014
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Tokai Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Novartis Venture FundsCorporate VentureBasel, SwitzerlandSeries E, Series D - III, Series D
Apple Tree PartnersVenture CapitalFairfield, Connecticut, United StatesSeries E, Series D - III, Series D, Series B
Undisclosed Angel InvestorsAngel Investor (Individual)Series E
Queensland BioCapital FundsSeries B
Qualifying Therapeutic Discovery ProjectGovernmentWashington, DC, United StatesGrant
See all 5 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies Aug 12, 2014 Nov 07, 2017 Patent
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies Jul 06, 2015 Jul 12, 2016 Patent
Lighter Nov 14, 2014 Jun 14, 2016 Patent
Prodrugs of steroidal cyp17 inhibitors/antiandrogens Jul 10, 2014 Jun 07, 2016 Patent
Treatment of prostate cancer Jun 24, 2014 Oct 13, 2015 Patent
See all 18 patents